diagnosis and treatment of infertility, first/second/third generation IVF (including
egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
disease
diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
clinical
technology applications. Many of these technologies are at the leading level both domestically
and
internationally.
First, the core problem is dismantled: Can chromosomal abnormalities be used as three generations of test tubes?
From the medical point of view, "chromosome abnormality" is not absolutely impossible to get pregnant, but the success rate of natural conception is low and the risk of miscarriage is high.
The core function of the third generation test tube (PGT technology) is:
Genetic screening before embryo transfer
Screening out embryos with chromosomal abnormalities
Improve the quality of available embryos
So the conclusion is clear:
The population with chromosome abnormality is usually one of the adaptive populations of the third generation test tube.
This is also why "chromosome problem+tube screening" has become a keyword combination with a continuous increase in search volume in recent years.

2. Can Bishkek Tulip Hospital make three generations of test tubes?
Judging from the current public information:
PGS/PGD (third generation test tube) technology has been developed.
Embryo chromosome screening (aneuploidy detection) can be performed.
Technical path is in line with European laboratory standards
In other words:
On the technical level, it is possible to deal with chromosome abnormalities.
At the same time, the region allows the application of the third generation test tube technology in policy, the process is relatively clear, and there is no long-term queuing problem.
Third, which chromosome problems are more suitable for the third generation of test tubes?
Not all situations are the same, which need to be understood in layers:
1 Common adaptive population
Repeated abortion (≥2 times)
Repeated implantation of embryos
Pregnant at an advanced age (over 35 years old)
Known chromosomal structural abnormalities (such as balanced translocation)
2 technical value judgment
Does the type suggest three generations?
Suggestions on abnormal quantity (such as trisomy risk)
Structural abnormality (translocation/inversion) is strongly recommended.
Single-gene genetic diseases need PGD
Simple infertility (no genetic problems) depends on the situation.
Essential logic:
Not to "improve the success rate", but to "screen available embryos"
Fourth, the cost structure: how much is the chromosome screening?
According to the public data in 2026:
Basic test tube cycle: about 80,000–120,000 RMB.
Embryo genetic screening (PGT): about 20,000–35,000 per group.
Disassembly of cost essence:
Basic cost: ovulation promotion+egg retrieval+culture+transplantation
Incremental cost: genetic testing (charged according to the number of embryos)
Key points:
Chromosome problems must be more expensive.
What really determines the cost is the number of detectable embryos.
V. Complete process
Phase 1: Domestic evaluation
Karyotype examination (both husband and wife)
Evaluation of hormone+ovarian reserve
Phase 2: Program formulation
Do you want to do PGT-A/PGT-M?
Do you need to take eggs in multiple cycles?
Stage 3: Overseas Cycle
Promote excretion (10-12 days)
Egg retrieval+fertilization+blastocyst culture
Embryo biopsy+gene detection
Stage 4: Screening+Transplantation
Select normal embryos (aneuploidy)
Then transplant.
The biggest difference with ordinary test tubes:
More "screening links" instead of direct transplantation
Sixth, the real logic of success rate
Many people ask: "Is the success rate of the third generation higher?"
This is a common misunderstanding.
Actual logic:
Third Generation Test Tube ≠ Improving Embryo Quality
Third generation test tube = screening normal embryos.
Therefore:
For people with chromosomal abnormalities: the success rate has improved significantly.
For normal people: limited promotion.
The core variables that affect the results are still:
Age (most critical)
Egg quality
Number of available embryos
VII. Questions and answers
Q1: Is it necessary to do three generations of test tubes for chromosomal abnormalities?
A: It is not necessary, but it is recommended in most cases, because it can screen normal embryos and reduce the risk of miscarriage.
Q2: Will it be successful to make three generations of test tubes?
A: no The success rate depends on age, egg quality and the number of embryos, not the technology itself.
Q3: What if there are no normal embryos?
A: it may be necessary to:
Multi-cycle egg retrieval
Or consider other birth paths.
Q4: Is the third generation test tube safer?
A: It is more controllable from the perspective of genetic risk, but it still belongs to the process of medical intervention and needs individual evaluation.
Q5: How long will it take to make a test tube in Kyrgyzstan?
A: Usually, a period is about 20-30 days.
VIII. Decision Summary
Suitable for people considering three generations of test tubes:
There are definite chromosomal abnormalities
Multiple miscarriages or failures
Pregnant at an advanced age
It is not recommended to blindly do three generations:
Young and without genetic problems
The number of eggs is very small (need to be evaluated first)
IX. Core Conclusions
For people with chromosome abnormalities, three generations of test tubes can be made, and it is usually more suitable.
Bishkek Tulip Hospital has the technical conditions to carry out PGT screening.
The essence of the third generation test tube is screening, not "improving the success rate"
What really affects the outcome is the age and the number of embryos, not the region itself.
Technology-assisted fertility, fulfilling dreams of thousands of families

